Literature DB >> 10428471

Regulatory role of metallothionein in NF-kappaB activation.

A Sakurai1, S Hara, N Okano, Y Kondo, J Inoue, N Imura.   

Abstract

Metallothionein (MT), a low molecular weight, cysteine-rich metal binding protein, has been associated with cytoprotection from heavy metals and cellular oxidants. As MT has the ability to scavenge hydroxyl radicals, MT may control intracellular redox status. In the present study, we examined whether MT regulates the activity of nuclear factor-kappaB (NF-kappaB), which is one of the redox-regulated transcription factors, using the MT null embryonic cell lines established from MT null mice. We first found that tumor necrosis factor (TNF)-induced activation of the binding of NF-kappaB protein to DNA in wild type MT+/+ cells was lower than that in MT-/- cells. The NF-kappaB activation in MT-expressing cells established from MT-/- cells by the transfection of mouse MT-1 gene was also significantly lower than that in MT-/- cells. In addition, transfection of the MT gene inhibited TNF-induced IkappaB degradation and suppressed NF-kappaB-dependent gene expression induced by TNF. These results demonstrate that MT may function as a negative regulator of NF-kappaB activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428471     DOI: 10.1016/s0014-5793(99)00839-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Activation of metallothionein transcription by 4-hydroxynonenal.

Authors:  Elena K Braithwaite; Michael D Mattie; Jonathan H Freedman
Journal:  J Biochem Mol Toxicol       Date:  2010 Sep-Oct       Impact factor: 3.642

2.  Protective role of metallothionein in acute lung injury induced by bacterial endotoxin.

Authors:  H Takano; K Inoue; R Yanagisawa; M Sato; A Shimada; T Morita; M Sawada; K Nakamura; C Sanbongi; T Yoshikawa
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

3.  Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia.

Authors:  Andrea D Raymond; Bethsebah Gekonge; Malavika S Giri; Aidan Hancock; Emmanouil Papasavvas; Jihed Chehimi; Andrew V Kossenkov; Andrew V Kossevkov; Calen Nicols; Malik Yousef; Karam Mounzer; Jane Shull; Jay Kostman; Louise Showe; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2010-06-15       Impact factor: 4.962

4.  Metallothionein modulates lipopolysaccharide-stimulated tumour necrosis factor expression in mouse peritoneal macrophages.

Authors:  Masako Kanekiyo; Norio Itoh; Atsuko Kawasaki; Akiko Matsuyama; Kimihiro Matsuda; Tsuyoshi Nakanishi; Keiichi Tanaka
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

5.  Metallothionein as an adaptive protein prevents diabetes and its toxicity.

Authors:  Lu Cai
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-04

Review 6.  Clinicopathological significance of metallothioneins in breast cancer.

Authors:  Rongxian Jin; Jingxiang Huang; Puay-Hoon Tan; Boon-Huat Bay
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

7.  Gene expression profiling in hepatic tissue of newly weaned pigs fed pharmacological zinc and phytase supplemented diets.

Authors:  Michelle M Martínez-Montemayor; Gretchen M Hill; Nancy E Raney; Valencia D Rilington; Robert J Tempelman; Jane E Link; Christopher P Wilkinson; Antonio M Ramos; Catherine W Ernst
Journal:  BMC Genomics       Date:  2008-09-17       Impact factor: 3.969

8.  Metallothionein mediates leukocyte chemotaxis.

Authors:  Xiuyun Yin; David A Knecht; Michael A Lynes
Journal:  BMC Immunol       Date:  2005-09-15       Impact factor: 3.615

9.  Inhibitory effects of armepavine against hepatic fibrosis in rats.

Authors:  Ting-Chun Weng; Chien-Chang Shen; Yung-Tsung Chiu; Yun-Lian Lin; Cheng-Deng Kuo; Yi-Tsau Huang
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

Review 10.  Molecular functions of metallothionein and its role in hematological malignancies.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2012-07-27       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.